Infection rates in patients from five rheumatoid arthritis (RA) registries: Contextualising an RA clinical trial programme

26Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.

Abstract

Objective Patients with rheumatoid arthritis (RA) have an increased risk of serious infections. Comparing infection rates across RA populations is complicated by differences in background infection risk, population composition and study methodology. We measured infection rates from five RA registries globally, with the aim to contextualise infection rates from an RA clinical trials population. Methods We used data from Consortium of Rheumatology Research of North America (CORRONA) (USA), Swedish Rheumatology Quality of Care Register (Sweden), Norfolk Arthritis Register (UK), CORRONA International (multiple countries) and Institute of Rheumatology Rheumatoid Arthritis (Japan) and an RA clinical trial programme (fostamatinib). Within each registry, we analysed a main cohort of all patients with RA from January 2000 to last available data. Infection definitions were harmonised across registries. Sensitivity analyses to address potential confounding explored subcohorts defined by disease activity, treatment change and/or prior comorbidities and restriction by calendar time or follow-up. Rates of infections were estimated and standardised to the trial population for age/sex and, in one sensitivity analysis also, for Health Assessment Questionnaire (HAQ) score. Results Overall, age/sex-standardised rates of hospitalised infection were quite consistent across registries (range 1.14-1.62 per 100 patient-years). Higher and more consistent rates across registries and with the trial programme overall were seen when adding standardisation for HAQ score (registry range 1.86-2.18, trials rate 2.92) or restricting to a treatment initiation subcohort followed for 18 months (registry range 0.99-2.84, trials rate 2.74). Conclusion This prospective, coordinated analysis of RA registries provided incidence rate estimates for infection events to contextualise infection rates from an RA clinical trial programme and demonstrated relative comparability of hospitalised infection rates across registries.

References Powered by Scopus

Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases

688Citations
N/AReaders
Get full text

The epidemiology of rheumatoid arthritis

603Citations
N/AReaders
Get full text

Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: Updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly

581Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Growing evidence of the safety of JAK inhibitors in patients with rheumatoid arthritis

179Citations
N/AReaders
Get full text

A large observational cohort study of rheumatoid arthritis, IORRA: Providing context for today’s treatment options

102Citations
N/AReaders
Get full text

Postapproval Comparative Safety Study of Tofacitinib and Biological Disease-Modifying Antirheumatic Drugs: 5-Year Results from a United States–Based Rheumatoid Arthritis Registry

100Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Yamanaka, H., Askling, J., Berglind, N., Franzen, S., Frisell, T., Garwood, C., … Nyberg, F. (2017). Infection rates in patients from five rheumatoid arthritis (RA) registries: Contextualising an RA clinical trial programme. RMD Open, 3(2). https://doi.org/10.1136/rmdopen-2017-000498

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 8

53%

Researcher 6

40%

Professor / Associate Prof. 1

7%

Readers' Discipline

Tooltip

Medicine and Dentistry 12

71%

Nursing and Health Professions 2

12%

Arts and Humanities 2

12%

Pharmacology, Toxicology and Pharmaceut... 1

6%

Save time finding and organizing research with Mendeley

Sign up for free